BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 19449407)

  • 1. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
    Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
    Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
    Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
    Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins.
    Nyström AM; Ekvall S; Strömberg B; Holmström G; Thuresson AC; Annerén G; Bondeson ML
    Acta Paediatr; 2009 Apr; 98(4):693-8. PubMed ID: 19120036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
    Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
    Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
    De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
    Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas.
    Pinna V; Lanari V; Daniele P; Consoli F; Agolini E; Margiotti K; Bottillo I; Torrente I; Bruselles A; Fusilli C; Ficcadenti A; Bargiacchi S; Trevisson E; Forzan M; Giustini S; Leoni C; Zampino G; Digilio MC; Dallapiccola B; Clementi M; Tartaglia M; De Luca A
    Eur J Hum Genet; 2015 Aug; 23(8):1068-71. PubMed ID: 25370043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.
    Bertola DR; Pereira AC; Passetti F; de Oliveira PS; Messiaen L; Gelb BD; Kim CA; Krieger JE
    Am J Med Genet A; 2005 Jul; 136(3):242-5. PubMed ID: 15948193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia.
    Banerjee S; Lei D; Liang S; Yang L; Liu S; Wei Z; Tang JP
    Oncotarget; 2017 Jun; 8(24):39695-39702. PubMed ID: 27980226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).
    Baralle D; Mattocks C; Kalidas K; Elmslie F; Whittaker J; Lees M; Ragge N; Patton MA; Winter RM; ffrench-Constant C
    Am J Med Genet A; 2003 May; 119A(1):1-8. PubMed ID: 12707950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple café au lait spots in familial patients with MAP2K2 mutation.
    Takenouchi T; Shimizu A; Torii C; Kosaki R; Takahashi T; Saya H; Kosaki K
    Am J Med Genet A; 2014 Feb; 164A(2):392-6. PubMed ID: 24311457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
    Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
    Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
    Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
    Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria.
    Carcavilla A; Pinto I; Muñoz-Pacheco R; Barrio R; Martin-Frías M; Ezquieta B
    Eur J Pediatr; 2011 Aug; 170(8):1069-74. PubMed ID: 21365175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.
    Rojnueangnit K; Xie J; Gomes A; Sharp A; Callens T; Chen Y; Liu Y; Cochran M; Abbott MA; Atkin J; Babovic-Vuksanovic D; Barnett CP; Crenshaw M; Bartholomew DW; Basel L; Bellus G; Ben-Shachar S; Bialer MG; Bick D; Blumberg B; Cortes F; David KL; Destree A; Duat-Rodriguez A; Earl D; Escobar L; Eswara M; Ezquieta B; Frayling IM; Frydman M; Gardner K; Gripp KW; Hernández-Chico C; Heyrman K; Ibrahim J; Janssens S; Keena BA; Llano-Rivas I; Leppig K; McDonald M; Misra VK; Mulbury J; Narayanan V; Orenstein N; Galvin-Parton P; Pedro H; Pivnick EK; Powell CM; Randolph L; Raskin S; Rosell J; Rubin K; Seashore M; Schaaf CP; Scheuerle A; Schultz M; Schorry E; Schnur R; Siqveland E; Tkachuk A; Tonsgard J; Upadhyaya M; Verma IC; Wallace S; Williams C; Zackai E; Zonana J; Lazaro C; Claes K; Korf B; Martin Y; Legius E; Messiaen L
    Hum Mutat; 2015 Nov; 36(11):1052-63. PubMed ID: 26178382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas.
    Trevisson E; Morbidoni V; Forzan M; Daolio C; Fumini V; Parrozzani R; Cassina M; Midena E; Salviati L; Clementi M
    Mol Genet Genomic Med; 2019 May; 7(5):e616. PubMed ID: 30843352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?
    Yapijakis C; Pachis N; Natsis S; Voumvourakis C
    In Vivo; 2016; 30(3):315-20. PubMed ID: 27107091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.
    Kaufmann D; Müller R; Bartelt B; Wolf M; Kunzi-Rapp K; Hanemann CO; Fahsold R; Hein C; Vogel W; Assum G
    Am J Hum Genet; 2001 Dec; 69(6):1395-400. PubMed ID: 11704931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.
    Stevenson DA; Viskochil DH; Rope AF; Carey JC
    Clin Genet; 2006 Mar; 69(3):246-53. PubMed ID: 16542390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.